- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/16 - Peri-condensed systems
Patent holdings for IPC class C07D 491/16
Total number of patents in this class: 181
10-year publication summary
10
|
16
|
13
|
5
|
19
|
17
|
21
|
23
|
11
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Patent GmbH | 5873 |
11 |
Idemitsu Kosan Co., Ltd. | 4208 |
7 |
eFFECTOR Therapeutics, Inc. | 68 |
5 |
UDC Ireland Limited | 476 |
5 |
LG Chem, Ltd. | 17594 |
4 |
The Regents of the University of California | 19857 |
4 |
Wisconsin Alumni Research Foundation | 3872 |
4 |
Mayo Foundation for Medical Education and Research | 3199 |
4 |
Duk San Neolux Co., Ltd. | 645 |
4 |
Promega Corporation | 571 |
4 |
Shandong Dyne Marine Biopharmaceutical Co., Ltd | 5 |
4 |
Merck Sharp & Dohme LLC | 3751 |
4 |
Novartis AG | 10886 |
3 |
Life Technologies Corporation | 3286 |
3 |
The General Hospital Corporation | 4715 |
3 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 286 |
3 |
Fundacion Del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III (f.s.p. Cnio) | 60 |
3 |
Samsung Display Co., Ltd. | 34472 |
2 |
Amgen Inc. | 4071 |
2 |
Konica Minolta, Inc. | 8701 |
2 |
Other owners | 100 |